BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15292699)

  • 1. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound.
    Rickes S; Ocran KW; Gerstenhauer G; Neye H; Wermke W
    Dig Dis; 2004; 22(1):81-6. PubMed ID: 15292699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.
    Mörk H; Ignee A; Schuessler G; Ott M; Dietrich CF
    Scand J Gastroenterol; 2007 May; 42(5):652-62. PubMed ID: 17454888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pancreatic metastases of renal cell carcinomas - evaluation of the contrast behavior at echo-enhanced power-Doppler sonography in comparison to primary pancreatic tumors].
    Rickes S; Flath B; Unkrodt K; Ocran K; Neye H; Lochs H; Wermke W
    Z Gastroenterol; 2001 Aug; 39(8):571-8. PubMed ID: 11558060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnosis of frequent pancreatic tumours with echo-enhanced power-Doppler sonography - presentation of case reports].
    Rickes S; Unkrodt K; Neye H; Ocran K; Lochs H; Wermke W
    Z Gastroenterol; 2002 Apr; 40(4):235-40. PubMed ID: 11961732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography.
    Rickes S; Unkrodt K; Neye H; Ocran KW; Wermke W
    Scand J Gastroenterol; 2002 Nov; 37(11):1313-20. PubMed ID: 12465731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echo-enhanced sonography--an increasingly used procedure for the differentiation of pancreatic tumors.
    Rickes S; Malfertheiner P
    Dig Dis; 2004; 22(1):32-8. PubMed ID: 15292693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diagnosing of small hepatocellular carcinomas by echo-enhanced power Doppler sonography in patients with cirrhosis.
    Rickes S; Schulze S; Neye H; Ocran KW; Wermke W
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):893-900. PubMed ID: 12867800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of echo-enhanced Doppler sonography in evaluation of transjugular intrahepatic portosystemic shunts.
    Uggowitzer MM; Kugler C; Machan L; Hausegger KA; Groell R; Quehenberger F; Lindbichler F; Schreyer H
    AJR Am J Roentgenol; 1998 Apr; 170(4):1041-6. PubMed ID: 9530056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
    Dörffel Y; Wermke W
    Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors.
    Strobel D; Krodel U; Martus P; Hahn EG; Becker D
    J Clin Ultrasound; 2000 Jan; 28(1):1-13. PubMed ID: 10602099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy.
    Konopke R; Bunk A; Kersting S
    Ultraschall Med; 2008 Sep; 29 Suppl 4():S203-9. PubMed ID: 18833498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
    Kim SH; Kim SH; Kim MA; Shin CI; Han JK; Choi BI
    Eur Radiol; 2015 Jul; 25(7):1946-57. PubMed ID: 25899412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis].
    Rickes S; Ocran K; Schulze S; Wermke W
    Ultraschall Med; 2002 Apr; 23(2):83-90. PubMed ID: 11961720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of B-mode and conventional colour/power Doppler ultrasound, contrast-enhanced Doppler ultrasound and spiral CT in the diagnosis of focal lesions of the liver: Results of a multicentre study.
    Beissert M; Delorme S; Mutze S; Lees WR; Bahner ML; Filimonow S; Gillams AR; Zuna I; Bauer A; Jenett M
    Ultraschall Med; 2002 Aug; 23(4):245-50. PubMed ID: 12226762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Harmonic imaging for improving diagnosis of liver tumors--preliminary report].
    Strobel D; Hahn EG; Becker D
    Z Gastroenterol; 2001 Apr; 39(4):287-9, 292-4. PubMed ID: 11367977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases.
    Albrecht T; Hoffmann CW; Schmitz SA; Schettler S; Overberg A; Germer CT; Wolf KJ
    AJR Am J Roentgenol; 2001 May; 176(5):1191-8. PubMed ID: 11312180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly-differentiated colorectal neuroendocrine tumour: CT differentiation from well-differentiated neuroendocrine tumour and poorly-differentiated adenocarcinomas.
    Kang JH; Kim SH; Han JK
    Eur Radiol; 2017 Sep; 27(9):3867-3876. PubMed ID: 28210802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.